Pfizer Inc. (PFE)$25.90
Market Cap: 135.38 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Pfizer Inc. (PFE).
HEALTHCARE
DRUG MANUFACTURERS - GENERAL
DCF ready
Valuation
14.8x
EV/FCF, 6.8% FCF yield
Quality
9.0%
ROIC, 14.5% FCF margin
Growth
8.5%
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 1.2x current ratio
Superinvestors
8
Top: Hillman Value Fund (3.7%)
Strengths to research
- Revenue compounded at 8.5% over five years.
- Free cash flow margin is healthy at 14.5%.
- Debt/equity looks manageable at 0.0x.
- 8 tracked superinvestors report a position.
Watchouts
No major valuation, balance sheet, or growth watchouts were detected by the static screen.
Annual data: 10 periods
Quarterly data: 21 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for PFE.
Grade D
35
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| PFE Target | Pfizer Inc. | $135.4B | 19.0x | 14.8x | 9.0% | 8.5% | 14.5% | N/A | N/A | N/A |
| SNY | Sanofi Aventis | $133.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| GILD | Gilead Sciences | $128.0B | 19.8x | 15.4x | 17.9% | 3.6% | 32.1% | N/A | 1.7x | N/A |
| AMGN | Amgen | $150.6B | 23.8x | 24.2x | 12.2% | 7.6% | 22.0% | N/A | 3.2x | N/A |
| BMY | Bristol-Myers Squibb | $101.9B | 17.2x | 10.6x | 11.1% | 2.5% | 26.7% | N/A | N/A | N/A |
| MRK | Merck & Co. | $208.5B | 16.8x | 15.7x | 34.7% | 9.4% | 19.0% | N/A | N/A | N/A |
| NVS | Novartis AG | $223.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| GSK | GSK plc | $79.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| RHHVF | Roche Holdings AG DIV RT | $263.8B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Financial Charts
No financial data available for PFE (annual).
8 superinvestors own PFE
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Richard Pzena Hancock Classic Value | 5,924,892 | $166M | 0.54% | 0.0% |
| Harry Burn Sound Shore | 2,870,421 | $81M | 2.70% | 0.0% |
| Prem Watsa Fairfax Financial Holdings | 990,900 | $28M | 1.43% | ▲ +32.0% |
| Torray Funds Torray Funds | 776,455 | $22M | 3.42% | 0.0% |
| Kahn Brothers Group Kahn Brothers Group | 484,733 | $14M | 2.41% | 0.0% |
| Hillman Value Fund Hillman Value Fund | 187,937 | $5M | 3.66% | 0.0% |
| Dodge & Cox Dodge & Cox | 88,564 | $2M | 0.00% | 0.0% |
| Mairs & Power Growth Fund Mairs & Power Growth Fund | 71,829 | $2M | 0.02% | 0.0% |